Skip to content
Visnia
CtrlK
EconomyAI buildoutMarket MapFundsWatchlist
Log in
Market cap
Revenue
Net income
Cash on hand
Gross margin
Net margin
EPS
P/E ratio
Search
Market mapFundsWatchlist
Visnia

EELITE PHARMACEUTICALS INC

EconomyAI buildoutMarket MapFundsWatchlist
Log in
E

ELITE PHARMACEUTICALS INC

  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Similar companies
  • News
  • Insider Transactions

News

News

  • Hello world!
    Feb 10, 2015Elite Pharmaceuticals Inc.

    Welcome to WordPress. This is your first post. Edit or delete it, then start blogging! The post Hello world! appeared first on Elite Pharmaceuticals Inc..

  • Elite Pharmaceuticals Awarded Second Canadian Patent for Abuse Deterrent Drug Formulation
    Dec 16, 2014Elite Pharmaceuticals Inc.

    Northvale, New Jersey, Tuesday, December 16, 2014: Elite Pharmaceuticals, Inc. (“Elite” or the “Company”) (OTCBB: ELTP) today announced the continued expansion of Elite’s intellectual property protection covering the Company’s abuse deterrent technology with the issuance of a second Canadian Patent, … Continue reading → The post Elite Pharmaceuticals Awarded Second Canadian Patent for Abuse Deterrent Drug Formulation appeared first on Elite Pharmaceuticals Inc..

  • ELITE PHARMACEUTICALS REPORTS SUCCESSFUL PIVOTAL BIOEQUIVALENCE STUDY FOR ABUSE-DETERRENT OXYCODONE PRODUCT ELI-201
    Dec 3, 2014Elite Pharmaceuticals Inc.

    Northvale, New Jersey, Wednesday, December 03, 2014: Elite Pharmaceuticals, Inc. (“Elite” or the “Company”) (OTCBB: ELTP) announced today successful results from a pivotal bioequivalence (BE) study for ELI-201, Elite’s twice daily abuse-deterrent oxycodone product which utilizes Elite’s proprietary pharmacological abuse-deterrent … Continue reading → The post ELITE PHARMACEUTICALS REPORTS SUCCESSFUL PIVOTAL BIOEQUIVALENCE STUDY FOR ABUSE-DETERRENT OXYCODONE PRODUCT ELI-201 appeared first on Elite Pharmaceuticals Inc..

  • Elite Pharmaceuticals, Inc. Reports Financial Results for the Second Quarter of Fiscal Year 2015
    Nov 14, 2014Elite Pharmaceuticals Inc.

    Revenues increase by 8% Conference Call Scheduled for Wednesday, November 19 at 11:00 AM EST Northvale, New Jersey, Friday, November 14, 2014: Elite Pharmaceuticals, Inc. (“Elite” or the “Company”) (OTCBB: ELTP), a specialty pharmaceutical company developing abuse-deterrent opioids and niche … Continue reading → The post Elite Pharmaceuticals, Inc. Reports Financial Results for the Second Quarter of Fiscal Year 2015 appeared first on Elite Pharmaceuticals Inc..

  • ELITE PHARMACEUTICALS ANNOUNCES NEW MANAGEMENT APPOINTMENTS
    Oct 24, 2014Elite Pharmaceuticals Inc.

    Northvale, New Jersey, Friday, October 24, 2014: Elite Pharmaceuticals, Inc. (“Elite” or the “Company”) (OTCBB: ELTP), a specialty pharmaceutical company developing a pipeline of abuse-deterrent opioids and niche generic products, today announced key management appointments of Dr. Kenneth Smith, J.D., … Continue reading → The post ELITE PHARMACEUTICALS ANNOUNCES NEW MANAGEMENT APPOINTMENTS appeared first on Elite Pharmaceuticals Inc..

  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Similar companies
  • News
  • Insider Transactions
$0.25Close · Sep 22, 2026